Similarly, γ′ fibrinogen acts as novel marker of thrombotic disease [109] while interleukin-1 receptor-like 1 (ST2) and interleukin-33 are important markers which are used to determine and assess cardiovascular risk [110]. Here, IL1RL1 is linked to thrombotic disease.